Pharma Journalist - Page 825 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

FDA Renews and Expands Its Portfolio of Simcyp Simulator (PBPK) Licenses

Sobi receives approval for Orfadin (nitisinone) Oral Suspension for the Treatment of HT-1

Biogen and Alkermes collaborates to develop and commercialize ALKS 8700

AstraZeneca submits sNDA for Tagrisso in 1st line EGFRm NSCLC in Japan

Takeda Initiates Phase 1 Clinical Trial of Zika Vaccine Candidate

Pharming submits application to FDA for RUCONEST to treat HAE

HITGEN & Boehringer enter DNA-Encoded Library Based Drug Discovery Research Collaboration

Brammer Bio Launches Gene Therapy Product Manufacturing Operations in Massachusetts

Recipharm equips a further three facilities for US serialisation

Catalyst Pharmaceuticals achieves positive results from second Phase 3 Clinical Trial